Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer
Wojciech Krajewski(Wroclaw Medical University), Ekaterina Laukhtina(Sechenov University), Steven Joniau, Rocco Francesco Delle Fave(Marche Polytechnic University), Luigi Candela(Sorbonne Université), Alessandro Tafuri(University of Verona), Roberto Contieri(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesco Soria(Medical University of Vienna), Bartosz Małkiewicz(Wroclaw Medical University), Joanna Chorbińska(Wroclaw Medical University), David D‘Andrea(Medical University of Vienna), Juan Gómez Rivas(Medico), Riccardo Mastroianni(Surgical Specialties (Canada)), Keiichiro Mori(Jikei University School of Medicine), Tim Muilwijk(KU Leuven), Sławomir Poletajew(Postgraduate School of Molecular Medicine), Łukasz Niedziela(Wroclaw Medical University), Giuseppe Simone(Istituti di Ricovero e Cura a Carattere Scientifico), Beatriz Gutiérrez Hidalgo(Hospital Clínico San Carlos), Agnieszka Hałoń(Wroclaw Medical University), Martina Maggi(Policlinico Umberto I), Petr Macek(Institute Mutualiste Montsouris), Ó. Rodríguez Faba(Puigvert Foundation), Jakub Horňák(Charles University), Mario Álvarez‐Maestro(Hospital Universitario La Paz), Alessia Cimadamore(University of Udine), Andrea Panunzio(University of Verona), Jeremy Yuen‐Chun Teoh(Chinese University of Hong Kong), José Daniel Subiela(Universidad de Alcalá), Alessandro Antonelli(University of Verona), Łukasz Nowak(Wroclaw Medical University), Roman Sosnowski(National Institute of Oncology), Daniel A. González‐Padilla(Clinica Universidad de Navarra), Benjamin I. Chung(Stanford Medicine), Shahrokh F. Shariat(Universitätszahnklinik Wien), Andrzej Tukiendorf(Wroclaw Medical University), Claudio Simeone(University of Brescia), Chiara Lonati(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Marco Moschini(Vita-Salute San Raffaele University), Juan Palou(Universitat Autònoma de Barcelona), Guillaume Ploussard(Yves Rocher (France)), Júlia Aumatell(Puigvert Foundation), Stefania Zamboni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Andrea Benedetto Galosi(Marche Polytechnic University), Francesco Del Giudice(Sapienza University of Rome), Jan Łaszkiewicz(Wroclaw Medical University), Marko Babjuk(Charles University), Paweł Rajwa(University College London), Carmen Mir(Fundación Instituto Valenciano de Oncología), Giuseppe Basile(Vita-Salute San Raffaele University)
Cited by 29
Related Papers
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289